Chemed Corp Executive Vice President Spencer Lee Sells Company Shares

Chemed Corp (NYSE:CHE), a company that operates through its two wholly-owned subsidiaries, VITAS Healthcare Corporation and Roto-Rooter, recently witnessed an insider sale. Executive Vice President Spencer Lee sold 2,000 shares of the company on March 28, 2024, according to a SEC Filing. This transaction has been part of a series of sales by the insider over the past year, with a total of 4,217 shares sold and no shares purchased.

The insider transaction history for Chemed Corp (NYSE:CHE) indicates a lack of insider purchases over the past year, with zero insiders buys recorded. In contrast, there have been 15 insider sells during the same period, suggesting a trend of insiders reducing their holdings in the company.On the valuation front, Chemed Corp (NYSE:CHE) shares were trading at $641.65 on the day of the insider's recent sale, bringing the company's market cap to $9.641 billion. The price-earnings ratio stands at 35.59, which is above both the industry median of 24.76 and the company's historical median price-earnings ratio.

The stock's price-to-GF-Value ratio is 1.16, with a GF Value of $554.50, indicating that Chemed Corp is considered Modestly Overvalued according to GuruFocus's valuation model. The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor related to past returns and growth, and future business performance estimates from Morningstar analysts.Chemed Corp's business includes its subsidiary VITAS Healthcare Corporation, which provides end-of-life care services, and Roto-Rooter, which offers plumbing and water cleanup services. The company's diverse operations have allowed it to maintain a presence in both the healthcare and service industries.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.